O95727 (CRTAM_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 95.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Cytotoxic and regulatory T-cell molecule Alternative name(s): Class-I MHC-restricted T-cell-associated molecule CD_antigen=CD355 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 393 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Interaction with CADM1 promotes natural killer (NK) cell cytotoxicity and interferon-gamma (IFN-gamma) secretion by CD8+ cells in vitro as well as NK cell-mediated rejection of tumors expressing CADM3 in vivo. Ref.4 UniProtKB Q149L7 |
| Subunit structure | |
| Subcellular location | Membrane; Single-pass type I membrane protein Potential. |
| Tissue specificity | In the immune system, expression is restricted to activated class-I MHC-restricted cells, including NKT and CD8 cells. Strongly expressed in spleen, thymus, small intestine, peripheral blood leukocyte, and in Purkinje neurons in cerebellum. Expressed at much lower levels in testis, ovary, colon, lung and lymphoid tissues. Ref.1 Ref.4 Ref.6 |
| Sequence similarities | Belongs to the nectin family. Ref.6 Contains 1 Ig-like C2-type (immunoglobulin-like) domain. Contains 1 Ig-like V-type (immunoglobulin-like) domain. |
| Sequence caution | The sequence BAD93067.1 differs from that shown. Reason: Erroneous initiation. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Adaptive immunity Immunity |
| Cellular component | Membrane |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | Immunoglobulin domain Repeat Signal Transmembrane Transmembrane helix |
| PTM | Disulfide bond Glycoprotein |
| Technical term | 3D-structure Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | cell recognition Inferred from direct assay Ref.4. Source: HGNC detection of tumor cellInferred from direct assay Ref.4. Source: HGNC positive regulation of cytokine secretionInferred from direct assay Ref.4. Source: HGNC positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell targetInferred from direct assay Ref.4. Source: HGNC |
| Cellular_component | integral to membrane Inferred from electronic annotation. Source: UniProtKB-KW plasma membraneInferred from direct assay Ref.4. Source: HGNC |
| Complete GO annotation... | |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 Ref.1 (identifier: O95727-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 Ref.2 (identifier: O95727-2) The sequence of this isoform differs from the canonical sequence as follows: 1-199: Missing. 200-216: HRGLQGRKLVAPFRFED → MWVKLLSIVAEFCFSPF | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 17 | 17 | Potential | ||||||||||||||||||||||
| Chain | 18 – 393 | 376 | Cytotoxic and regulatory T-cell molecule | PRO_0000292602 | |||||||||||||||||||||
Regions | |||||||||||||||||||||||||
| Topological domain | 18 – 287 | 270 | Extracellular Potential | ||||||||||||||||||||||
| Transmembrane | 288 – 308 | 21 | Helical; Potential | ||||||||||||||||||||||
| Topological domain | 309 – 393 | 85 | Cytoplasmic Potential | ||||||||||||||||||||||
| Domain | 18 – 114 | 97 | Ig-like V-type | ||||||||||||||||||||||
| Domain | 118 – 210 | 93 | Ig-like C2-type | ||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||
| Glycosylation | 21 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||
| Glycosylation | 87 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||
| Glycosylation | 178 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||
| Disulfide bond | 38 ↔ 98 | Ref.7 | |||||||||||||||||||||||
| Disulfide bond | 141 ↔ 196 | By similarity | |||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||
| Alternative sequence | 1 – 199 | 199 | Missing in isoform 2. Ref.2 | VSP_052471 | |||||||||||||||||||||
| Alternative sequence | 200 – 216 | 17 | HRGLQ…FRFED → MWVKLLSIVAEFCFSPF in isoform 2. Ref.2 | VSP_052472 | |||||||||||||||||||||
| Natural variant | 16 | 1 | E → A. Corresponds to variant rs35411582 [ dbSNP | Ensembl ]. | VAR_049868 | |||||||||||||||||||||
| Natural variant | 78 | 1 | A → D. Corresponds to variant rs34397316 [ dbSNP | Ensembl ]. | VAR_049869 | |||||||||||||||||||||
| Natural variant | 173 | 1 | D → G. Corresponds to variant rs35136295 [ dbSNP | Ensembl ]. | VAR_049870 | |||||||||||||||||||||
| Natural variant | 321 | 1 | K → R. Ref.1 Corresponds to variant rs2272094 [ dbSNP | Ensembl ]. | VAR_032999 | |||||||||||||||||||||
| Natural variant | 368 | 1 | A → G. Ref.3 Corresponds to variant rs1916036 [ dbSNP | Ensembl ]. | VAR_033000 | |||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||
| Sequence conflict | 65 | 1 | A → V in AAH70266. Ref.3 | ||||||||||||||||||||||
| Sequence conflict | 315 | 1 | A → T in AAH70266. Ref.3 | ||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||
| Beta strand | 22 – 29 | 8 | |||||||||||||||||||||||
| Beta strand | 34 – 39 | 6 | |||||||||||||||||||||||
| Beta strand | 47 – 51 | 5 | |||||||||||||||||||||||
| Beta strand | 57 – 60 | 4 | |||||||||||||||||||||||
| Beta strand | 72 – 77 | 6 | |||||||||||||||||||||||
| Beta strand | 80 – 87 | 8 | |||||||||||||||||||||||
| Helix | 90 – 92 | 3 | |||||||||||||||||||||||
| Beta strand | 94 – 115 | 22 | |||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "A molecular analysis of NKT cells: identification of a class-I restricted T cell-associated molecule (CRTAM)." Kennedy J., Vicari A.P., Saylor V., Zurawski S.M., Copeland N.G., Gilbert D.J., Jenkins N.A., Zlotnik A. J. Leukoc. Biol. 67:725-734(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, VARIANT ARG-321. |
| [2] | Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S., Ohara O., Nagase T., Kikuno R.F. Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Brain. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), VARIANT GLY-368. Tissue: Peripheral blood. |
| [4] | "The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM." Boles K.S., Barchet W., Diacovo T., Cella M., Colonna M. Blood 106:779-786(2005) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH CADM1, TISSUE SPECIFICITY. |
| [5] | "Nectin-like protein 2 defines a subset of T-cell zone dendritic cells and is a ligand for class-I-restricted T-cell-associated molecule." Galibert L., Diemer G.S., Liu Z., Johnson R.S., Smith J.L., Walzer T., Comeau M.R., Rauch C.T., Wolfson M.F., Sorensen R.A., Van der Vuurst de Vries A.-R., Branstetter D.G., Koelling R.M., Scholler J., Fanslow W.C., Baum P.R., Derry J.M., Yan W. J. Biol. Chem. 280:21955-21964(2005) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH CADM1. |
| [6] | "Human class-I restricted T cell associated molecule is highly expressed in the cerebellum and is a marker for activated NKT and CD8+ T lymphocytes." Patino-Lopez G., Hevezi P., Lee J., Willhite D., Verge G.M., Lechner S.M., Ortiz-Navarrete V., Zlotnik A. J. Neuroimmunol. 171:145-155(2006) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [7] | "Structure analysis of human class-I MHC restricted T-cell associated molecule." New York structural genomics research consortium (NYSGRC) Submitted (MAY-2011) to the PDB data bank Cited for: X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 18-117, DISULFIDE BOND. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF001622 mRNA. Translation: AAC80267.1. AB209830 mRNA. Translation: BAD93067.1. Different initiation. BC070266 mRNA. Translation: AAH70266.1. | ||||||||||||
| IPI | IPI00159048. IPI00847808. | ||||||||||||
| RefSeq | NP_062550.2. NM_019604.2. | ||||||||||||
| UniGene | Hs.159523. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | O95727. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| STRING | 9606.ENSP00000227348. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | O95727. | ||||||||||||
| PRIDE | O95727. | ||||||||||||
Protocols and materials databases | |||||||||||||
| DNASU | 56253. | ||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000227348; ENSP00000227348; ENSG00000109943. ENST00000533709; ENSP00000433728; ENSG00000109943. | ||||||||||||
| GeneID | 56253. | ||||||||||||
| KEGG | hsa:56253. | ||||||||||||
| UCSC | uc001pyj.3. human. uc001pyk.3. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 56253. | ||||||||||||
| GeneCards | GC11P122743. | ||||||||||||
| H-InvDB | HIX0035844. | ||||||||||||
| HGNC | HGNC:24313. CRTAM. | ||||||||||||
| HPA | HPA054595. | ||||||||||||
| MIM | 612597. gene. | ||||||||||||
| neXtProt | NX_O95727. | ||||||||||||
| PharmGKB | PA145149072. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | NOG72056. | ||||||||||||
| HOGENOM | HOG000008690. | ||||||||||||
| HOVERGEN | HBG053014. | ||||||||||||
| InParanoid | O95727. | ||||||||||||
| KO | K16361. | ||||||||||||
| OMA | KKCNTTS. | ||||||||||||
| OrthoDB | EOG4ZKJMT. | ||||||||||||
| PhylomeDB | O95727. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Reactome | REACT_6900. Immune System. | ||||||||||||
Gene expression databases | |||||||||||||
| Bgee | O95727. | ||||||||||||
| CleanEx | HS_CRTAM. | ||||||||||||
| Genevestigator | O95727. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | 2.60.40.10. 2 hits. | ||||||||||||
| InterPro | IPR013162. CD80_C2-set. IPR007110. Ig-like_dom. IPR013783. Ig-like_fold. IPR003599. Ig_sub. IPR013106. Ig_V-set. [Graphical view] | ||||||||||||
| Pfam | PF08205. C2-set_2. 1 hit. PF07686. V-set. 1 hit. [Graphical view] | ||||||||||||
| SMART | SM00409. IG. 1 hit. [Graphical view] | ||||||||||||
| PROSITE | PS50835. IG_LIKE. 2 hits. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| EvolutionaryTrace | O95727. | ||||||||||||
| GenomeRNAi | 56253. | ||||||||||||
| NextBio | 61889. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | CRTAM_HUMAN | ||||||||
| Accession | Primary (citable) accession number: O95727 Secondary accession number(s): Q59EI1, Q6IRX2 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human cell differentiation molecules CD nomenclature of surface proteins of human leucocytes and list of entries |
| Human chromosome 11 Human chromosome 11: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
